ABL Bio

298380.KQ

19.50 USD

0.79

+4.22%

Overview

Last close

19.50 usd

Market cap

936.80M usd

52 week high

30.50 usd

52 week low

11.47 usd

Target price

32.44 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

42.6648

Price/Book Value

7.3328

Enterprise Value

819.78M usd

EV/Revenue

37.0101

EV/EBITDA

-32.1061

Key financials

Revenue TTM

22.58M usd

Gross Profit TTM

46.06M usd

EBITDA TTM

-26.33M usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

120.71B usd

Net debt

42.00B usd

About

ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio Inc.is headquartered in Seongnam-si, South Korea.

Symbol
298380.KQ
Exchange
KQ
Isin
KR7298380007
Country
South Korea
Sector
Healthcare
Industry
Biotechnology
CEO
Dr. Sang Hoon Lee Ph.D.
Headquarter
Seongnam-si
Web site
https://www.ablbio.com

Related indices

JAKOTA Mid and Small Cap 2000 Index

114.65 -0.31%